Drug Development

Articles

Through the agreement, Emergent will manufacture the vaccine, which is formulated based on Novavax’s proprietary recombinant protein nanoparticle technology platform and its Matrix-M adjuvant to boost immune responses.

Emergent and Novavx Sign Agreement for Experimental COVID-19 Vaccine

The new center expands the company’s R&D capabilities and will help it advance its portfolio of rare disease gene therapy programs.

Amicus Opens New Gene Therapy Center of Excellence

Research from data and analytics company GlobalData shows that CAR-T cell therapy innovations across APAC will make the global market for these therapies more competitive.

Innovations in CAR-T Therapies Across APAC Region Intensify Global Market Competition

FDA issued a notice to drug compounders regarding the transition of licensure of biologics to the Public Health Service Act. 

Biologics and Compounding Rules Change

A guidance document answers questions regarding the transition of biologics applications from under the FD&C Act to the PHS Act.

FDA Provides Answers to Biologics License Questions

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.


Keeping Toxicity to a Minimum

Metrology has the potential to not only prevent harm to patients but also to support innovative therapeutic options.


Going with the Flow

The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.


By Popular Demand: The Growth of Biopharma Outsourcing

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?

Fast vs. Formulated?

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another. 

Formulation and Drug Delivery